According to a new study, heart attack patients who are in need of emergency procedures are less likely to die or suffer further serious cardiac events if they are given the new blood thinner Brilinta rather than Plavix, the current standard treatment. Scientists also found that Brilinta patients were at no greater risk for major bleeding than those taking Plavix.
Read full story >